世界の血漿分画&血液製剤市場予測 2021年-2026年

【英語タイトル】Global Plasma Fractionation and Blood Product Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9624)・商品コード:LPI21MY9624
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:103
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「血漿分画&血液製剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、凝固因子、免疫グロブリン、アルブミン、その他など、用途別には、免疫学、血液学、その他などにセグメント区分してまとめました。血漿分画&血液製剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・血漿分画&血液製剤の世界市場概要(サマリー)
・血漿分画&血液製剤の企業別販売量・売上
・血漿分画&血液製剤の企業別市場シェア
・血漿分画&血液製剤の世界市場規模 2016年-2021年:種類別(凝固因子、免疫グロブリン、アルブミン、その他)
・血漿分画&血液製剤の世界市場規模 2016年-2021年:用途別(免疫学、血液学、その他)
・血漿分画&血液製剤の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・血漿分画&血液製剤のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・血漿分画&血液製剤のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・血漿分画&血液製剤の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・血漿分画&血液製剤市場の成長要因・課題・動向
・血漿分画&血液製剤の世界市場予測 2021年-2026年
・血漿分画&血液製剤の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・血漿分画&血液製剤のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・血漿分画&血液製剤のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・血漿分画&血液製剤の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・血漿分画&血液製剤の世界市場予測:種類別(凝固因子、免疫グロブリン、アルブミン、その他)
・血漿分画&血液製剤の世界市場予測:用途別(免疫学、血液学、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Plasma Fractionation and Blood Product will have significant change from previous year. By the most conservative estimates of global Plasma Fractionation and Blood Product market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Plasma Fractionation and Blood Product market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Fractionation and Blood Product market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Coagulation Factor
Immune Globulin
Albumin
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Immunology
Hematology
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma Fractionation and Blood Product Consumption 2016-2026
2.1.2 Plasma Fractionation and Blood Product Consumption CAGR by Region
2.2 Plasma Fractionation and Blood Product Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Other
2.3 Plasma Fractionation and Blood Product Sales by Type
2.3.1 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
2.3.2 Global Plasma Fractionation and Blood Product Revenue and Market Share by Type (2016-2021)
2.3.3 Global Plasma Fractionation and Blood Product Sale Price by Type (2016-2021)
2.4 Plasma Fractionation and Blood Product Segment by Application
2.4.1 Immunology
2.4.2 Hematology
2.4.3 Other
2.5 Plasma Fractionation and Blood Product Sales by Application
2.5.1 Global Plasma Fractionation and Blood Product Sale Market Share by Application (2016-2021)
2.5.2 Global Plasma Fractionation and Blood Product Revenue and Market Share by Application (2016-2021)
2.5.3 Global Plasma Fractionation and Blood Product Sale Price by Application (2016-2021)

3 Global Plasma Fractionation and Blood Product by Company
3.1 Global Plasma Fractionation and Blood Product Sales Market Share by Company
3.1.1 Global Plasma Fractionation and Blood Product Sales by Company (2019-2021)
3.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Company (2019-2021)
3.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Company
3.2.1 Global Plasma Fractionation and Blood Product Revenue by Company (2019-2021)
3.2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Company (2019-2021)
3.3 Global Plasma Fractionation and Blood Product Sale Price by Company
3.4 Global Manufacturers Plasma Fractionation and Blood Product Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Fractionation and Blood Product Product Location Distribution
3.4.2 Players Plasma Fractionation and Blood Product Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Plasma Fractionation and Blood Product by Region
4.1 Global Plasma Fractionation and Blood Product by Region
4.1.1 Global Plasma Fractionation and Blood Product Sales by Region
4.1.2 Global Plasma Fractionation and Blood Product Revenue by Region
4.2 Americas Plasma Fractionation and Blood Product Sales Growth
4.3 APAC Plasma Fractionation and Blood Product Sales Growth
4.4 Europe Plasma Fractionation and Blood Product Sales Growth
4.5 Middle East & Africa Plasma Fractionation and Blood Product Sales Growth

5 Americas
5.1 Americas Plasma Fractionation and Blood Product Sales by Country
5.1.1 Americas Plasma Fractionation and Blood Product Sales by Country (2016-2021)
5.1.2 Americas Plasma Fractionation and Blood Product Revenue by Country (2016-2021)
5.2 Americas Plasma Fractionation and Blood Product Sales by Type
5.3 Americas Plasma Fractionation and Blood Product Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Plasma Fractionation and Blood Product Sales by Region
6.1.1 APAC Plasma Fractionation and Blood Product Sales by Region (2016-2021)
6.1.2 APAC Plasma Fractionation and Blood Product Revenue by Region (2016-2021)
6.2 APAC Plasma Fractionation and Blood Product Sales by Type
6.3 APAC Plasma Fractionation and Blood Product Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Plasma Fractionation and Blood Product by Country
7.1.1 Europe Plasma Fractionation and Blood Product Sales by Country (2016-2021)
7.1.2 Europe Plasma Fractionation and Blood Product Revenue by Country (2016-2021)
7.2 Europe Plasma Fractionation and Blood Product Sales by Type
7.3 Europe Plasma Fractionation and Blood Product Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Plasma Fractionation and Blood Product by Country
8.1.1 Middle East & Africa Plasma Fractionation and Blood Product Sales by Country (2016-2021)
8.1.2 Middle East & Africa Plasma Fractionation and Blood Product Revenue by Country (2016-2021)
8.2 Middle East & Africa Plasma Fractionation and Blood Product Sales by Type
8.3 Middle East & Africa Plasma Fractionation and Blood Product Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Plasma Fractionation and Blood Product Distributors
10.3 Plasma Fractionation and Blood Product Customer

11 Global Plasma Fractionation and Blood Product Market Forecast
11.1 Global Plasma Fractionation and Blood Product Forecast by Region
11.1.1 Global Plasma Fractionation and Blood Product Forecast by Regions (2021-2026)
11.2.2 Global Plasma Fractionation and Blood Product Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Plasma Fractionation and Blood Product Forecast by Type
11.7 Global Plasma Fractionation and Blood Product Forecast by Application

12 Key Players Analysis
12.1 Takeda
12.1.1 Takeda Company Information
12.1.2 Takeda Plasma Fractionation and Blood Product Product Offered
12.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Takeda Main Business Overview
12.1.5 Takeda Latest Developments
12.2 CSL
12.2.1 CSL Company Information
12.2.2 CSL Plasma Fractionation and Blood Product Product Offered
12.2.3 CSL Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 CSL Main Business Overview
12.2.5 CSL Latest Developments
12.3 Grifols
12.3.1 Grifols Company Information
12.3.2 Grifols Plasma Fractionation and Blood Product Product Offered
12.3.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Grifols Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Octapharma
12.4.1 Octapharma Company Information
12.4.2 Octapharma Plasma Fractionation and Blood Product Product Offered
12.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Octapharma Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Kedrion
12.5.1 Kedrion Company Information
12.5.2 Kedrion Plasma Fractionation and Blood Product Product Offered
12.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Kedrion Main Business Overview
12.5.5 Kedrion Latest Developments
12.6 LFB Group
12.6.1 LFB Group Company Information
12.6.2 LFB Group Plasma Fractionation and Blood Product Product Offered
12.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 LFB Group Main Business Overview
12.6.5 LFB Group Latest Developments
12.7 Biotest
12.7.1 Biotest Company Information
12.7.2 Biotest Plasma Fractionation and Blood Product Product Offered
12.7.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Biotest Main Business Overview
12.7.5 Biotest Latest Developments
12.8 BPL
12.8.1 BPL Company Information
12.8.2 BPL Plasma Fractionation and Blood Product Product Offered
12.8.3 BPL Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 BPL Main Business Overview
12.8.5 BPL Latest Developments
12.9 RAAS
12.9.1 RAAS Company Information
12.9.2 RAAS Plasma Fractionation and Blood Product Product Offered
12.9.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 RAAS Main Business Overview
12.9.5 RAAS Latest Developments
12.10 CBPO
12.10.1 CBPO Company Information
12.10.2 CBPO Plasma Fractionation and Blood Product Product Offered
12.10.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 CBPO Main Business Overview
12.10.5 CBPO Latest Developments
12.11 Hualan Bio
12.11.1 Hualan Bio Company Information
12.11.2 Hualan Bio Plasma Fractionation and Blood Product Product Offered
12.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Hualan Bio Main Business Overview
12.11.5 Hualan Bio Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Plasma Fractionation and Blood Product Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Coagulation Factor
Table 3. Major Players of Immune Globulin
Table 4. Major Players of Albumin
Table 5. Major Players of Other
Table 6. Global Plasma Fractionation and Blood Product Sales by Type (2016-2021) & (K Units)
Table 7. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
Table 8. Global Plasma Fractionation and Blood Product Revenue by Type (2016-2021) & ($ million)
Table 9. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2016-2021)
Table 10. Global Plasma Fractionation and Blood Product Sale Price by Type (2016-2021)
Table 11. Global Plasma Fractionation and Blood Product Sales by Application (2016-2021) & (K Units)
Table 12. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
Table 13. Global Plasma Fractionation and Blood Product Value by Application (2016-2021)
Table 14. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2016-2021)
Table 15. Global Plasma Fractionation and Blood Product Sale Price by Application (2016-2021)
Table 16. Global Plasma Fractionation and Blood Product Sales by Company (2019-2021) & (K Units)
Table 17. Global Plasma Fractionation and Blood Product Sales Market Share by Company (2019-2021)
Table 18. Global Plasma Fractionation and Blood Product Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Plasma Fractionation and Blood Product Revenue Market Share by Company (2019-2021)
Table 20. Global Plasma Fractionation and Blood Product Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Plasma Fractionation and Blood Product Producing Area Distribution and Sales Area
Table 22. Players Plasma Fractionation and Blood Product Products Offered
Table 23. Plasma Fractionation and Blood Product Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Plasma Fractionation and Blood Product Sales by Region (2016-2021) (K Units)
Table 27. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2016-2021)
Table 28. Global Plasma Fractionation and Blood Product Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2016-2021)
Table 30. Americas Plasma Fractionation and Blood Product Sales by Country (2016-2021) & (K Units)
Table 31. Americas Plasma Fractionation and Blood Product Sales Market Share by Country (2016-2021)
Table 32. Americas Plasma Fractionation and Blood Product Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Plasma Fractionation and Blood Product Revenue Market Share by Country (2016-2021)
Table 34. Americas Plasma Fractionation and Blood Product Sales by Type (2016-2021) & (K Units)
Table 35. Americas Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
Table 36. Americas Plasma Fractionation and Blood Product Sales by Application (2016-2021) & (K Units)
Table 37. Americas Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
Table 38. APAC Plasma Fractionation and Blood Product Sales by Region (2016-2021) & (K Units)
Table 39. APAC Plasma Fractionation and Blood Product Sales Market Share by Region (2016-2021)
Table 40. APAC Plasma Fractionation and Blood Product Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Plasma Fractionation and Blood Product Revenue Market Share by Region (2016-2021)
Table 42. APAC Plasma Fractionation and Blood Product Sales by Type (2016-2021) & (K Units)
Table 43. APAC Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
Table 44. APAC Plasma Fractionation and Blood Product Sales by Application (2016-2021) & (K Units)
Table 45. APAC Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
Table 46. Europe Plasma Fractionation and Blood Product Sales by Country (2016-2021) & (K Units)
Table 47. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2016-2021)
Table 48. Europe Plasma Fractionation and Blood Product Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country (2016-2021)
Table 50. Europe Plasma Fractionation and Blood Product Sales by Type (2016-2021) & (K Units)
Table 51. Europe Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
Table 52. Europe Plasma Fractionation and Blood Product Sales by Application (2016-2021) & (K Units)
Table 53. Europe Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Plasma Fractionation and Blood Product Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Plasma Fractionation and Blood Product Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Plasma Fractionation and Blood Product Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Plasma Fractionation and Blood Product
Table 63. Key Application and Potential Industries of Plasma Fractionation and Blood Product
Table 64. Key Challenges of Plasma Fractionation and Blood Product
Table 65. Key Trends of Plasma Fractionation and Blood Product
Table 66. Plasma Fractionation and Blood Product Distributors List
Table 67. Plasma Fractionation and Blood Product Customer List
Table 68. Global Plasma Fractionation and Blood Product Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Plasma Fractionation and Blood Product Consumption Market Forecast by Region
Table 70. Global Plasma Fractionation and Blood Product Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Plasma Fractionation and Blood Product Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Plasma Fractionation and Blood Product Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Plasma Fractionation and Blood Product Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Plasma Fractionation and Blood Product Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Plasma Fractionation and Blood Product Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Plasma Fractionation and Blood Product Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Plasma Fractionation and Blood Product Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Plasma Fractionation and Blood Product Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Plasma Fractionation and Blood Product Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Plasma Fractionation and Blood Product Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Plasma Fractionation and Blood Product Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Plasma Fractionation and Blood Product Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Application (2021-2026)
Table 88. Takeda Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 89. Takeda Plasma Fractionation and Blood Product Product Offered
Table 90. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. Takeda Main Business
Table 92. Takeda Latest Developments
Table 93. CSL Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 94. CSL Plasma Fractionation and Blood Product Product Offered
Table 95. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. CSL Main Business
Table 97. CSL Latest Developments
Table 98. Grifols Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 99. Grifols Plasma Fractionation and Blood Product Product Offered
Table 100. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Grifols Main Business
Table 102. Grifols Latest Developments
Table 103. Octapharma Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 104. Octapharma Plasma Fractionation and Blood Product Product Offered
Table 105. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. Octapharma Main Business
Table 107. Octapharma Latest Developments
Table 108. Kedrion Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 109. Kedrion Plasma Fractionation and Blood Product Product Offered
Table 110. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. Kedrion Main Business
Table 112. Kedrion Latest Developments
Table 113. LFB Group Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 114. LFB Group Plasma Fractionation and Blood Product Product Offered
Table 115. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. LFB Group Main Business
Table 117. LFB Group Latest Developments
Table 118. Biotest Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 119. Biotest Plasma Fractionation and Blood Product Product Offered
Table 120. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. Biotest Main Business
Table 122. Biotest Latest Developments
Table 123. BPL Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 124. BPL Plasma Fractionation and Blood Product Product Offered
Table 125. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. BPL Main Business
Table 127. BPL Latest Developments
Table 128. RAAS Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 129. RAAS Plasma Fractionation and Blood Product Product Offered
Table 130. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 131. RAAS Main Business
Table 132. RAAS Latest Developments
Table 133. CBPO Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 134. CBPO Plasma Fractionation and Blood Product Product Offered
Table 135. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 136. CBPO Main Business
Table 137. CBPO Latest Developments
Table 138. Hualan Bio Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 139. Hualan Bio Plasma Fractionation and Blood Product Product Offered
Table 140. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 141. Hualan Bio Main Business
Table 142. Hualan Bio Latest Developments
List of Figures
Figure 1. Picture of Plasma Fractionation and Blood Product
Figure 2. Plasma Fractionation and Blood Product Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Fractionation and Blood Product Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Plasma Fractionation and Blood Product Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Plasma Fractionation and Blood Product Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Coagulation Factor
Figure 10. Product Picture of Immune Globulin
Figure 11. Product Picture of Albumin
Figure 12. Product Picture of Other
Figure 13. Global Plasma Fractionation and Blood Product Sales Market Share by Type in 2020
Figure 14. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2016-2021)
Figure 15. Plasma Fractionation and Blood Product Consumed in Immunology
Figure 16. Global Plasma Fractionation and Blood Product Market: Immunology (2016-2021) & (K Units)
Figure 17. Plasma Fractionation and Blood Product Consumed in Hematology
Figure 18. Global Plasma Fractionation and Blood Product Market: Hematology (2016-2021) & (K Units)
Figure 19. Plasma Fractionation and Blood Product Consumed in Other
Figure 20. Global Plasma Fractionation and Blood Product Market: Other (2016-2021) & (K Units)
Figure 21. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
Figure 22. Global Plasma Fractionation and Blood Product Revenue Market Share by Application in 2020
Figure 23. Plasma Fractionation and Blood Product Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Plasma Fractionation and Blood Product Revenue Market Share by Company in 2020
Figure 25. Global Plasma Fractionation and Blood Product Sales Market Share by Regions (2016-2021)
Figure 26. Global Plasma Fractionation and Blood Product Revenue Market Share by Region in 2020
Figure 27. Americas Plasma Fractionation and Blood Product Sales 2016-2021 (K Units)
Figure 28. Americas Plasma Fractionation and Blood Product Revenue 2016-2021 ($ Millions)
Figure 29. APAC Plasma Fractionation and Blood Product Sales 2016-2021 (K Units)
Figure 30. APAC Plasma Fractionation and Blood Product Revenue 2016-2021 ($ Millions)
Figure 31. Europe Plasma Fractionation and Blood Product Sales 2016-2021 (K Units)
Figure 32. Europe Plasma Fractionation and Blood Product Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Plasma Fractionation and Blood Product Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Plasma Fractionation and Blood Product Revenue 2016-2021 ($ Millions)
Figure 35. Americas Plasma Fractionation and Blood Product Sales Market Share by Country in 2020
Figure 36. Americas Plasma Fractionation and Blood Product Revenue Market Share by Country in 2020
Figure 37. Americas Plasma Fractionation and Blood Product Sales Market Share by Type in 2020
Figure 38. Americas Plasma Fractionation and Blood Product Sales Market Share by Application in 2020
Figure 39. United States Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Plasma Fractionation and Blood Product Sales Market Share by Region in 2020
Figure 44. APAC Plasma Fractionation and Blood Product Revenue Market Share by Regions in 2020
Figure 45. APAC Plasma Fractionation and Blood Product Sales Market Share by Type in 2020
Figure 46. APAC Plasma Fractionation and Blood Product Sales Market Share by Application in 2020
Figure 47. China Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Plasma Fractionation and Blood Product Sales Market Share by Country in 2020
Figure 54. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country in 2020
Figure 55. Europe Plasma Fractionation and Blood Product Sales Market Share by Type in 2020
Figure 56. Europe Plasma Fractionation and Blood Product Sales Market Share by Application in 2020
Figure 57. Germany Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Plasma Fractionation and Blood Product Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Application in 2020
Figure 66. Egypt Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Plasma Fractionation and Blood Product Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


★調査レポート[世界の血漿分画&血液製剤市場予測 2021年-2026年] (コード:LPI21MY9624)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血漿分画&血液製剤市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆